It is reported that the underlying anti-cancer mechanisms of NDGA was to inhibit a series of cancer related signaling molecules, such as IGF-1R, HER2, and mTORC1 (Zavodovskaya et al., 2008; Zhang et al., 2012). The gene discussed is IGF1R; the disease is cancer.